China Biologic Lands $4.76B Value In Take-Private Deal
Chinese pharmaceutical company China Biologic said Thursday it's agreed to be taken private by a consortium of buyers in a transaction valuing the business at $4.76 billion and guided by six...To view the full article, register now.
Already a subscriber? Click here to view full article